Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
- Resource Type
- Article
- Authors
- Fumagalli, Debora; Gelber, Richard D; Goulioti, Theodora; Hiltbrunner, Anita; Hui, Rita; Roschitzki, Heidi; Ruepp, Barbara; Boyle, Fran; Stahel, Rolf; Aebi, Stefan; Coates, Alan S; Goldhirsch, Aron; Karlsson, Per; Kössler, Ingrid; Fournarakou, Stamatina; Gasca, Adriana; Pfister, Rita; Ribeli-Hofmann, Sabrina; Weber, Magdelena; Celotto, Daniela; Comune, Carmen; Frapolli, Michela; Sánchez-Hohl, Magdalena; Huang, Hui; Mahoney, Caitlin; Price, Karen; Scott, Karolyn; Shaw, Holly; Fischer, Susan; Greco, Monica; King, Colleen; Andrighetto, Stefania; Piccart-Gebhart, Martine; Findlay, Heather; Jenkins, Michelle; Karantza, Vassiliki; Mejia, Jaime; Schneier, Patrick; Loi, Sherene ; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Hervé; Jerusalem, Guy; Bartsch, Rupert; Rabaglio-Poretti, Manuela; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan, Meredith M; André, Fabrice
- Source
- In The Lancet Oncology March 2019 20(3):371-382
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045